Increased Focus on Protein Intake Among Geriatric Patients

May 2, 2018 updated by: Lars Holm, University of Copenhagen

Increased Focus on Protein Intake Among Geriatric Patients During Hospitalization: Serving and Acceptance of Protein Enriched Meals in the Morning and Before Bedtime, as Well as Nutritional Guidance by a Clinical Dietician.

Up to approximately 38 (unknown drop-out rate) geriatric patients (at least 65 years old) are recruited from a Geriatric ward at Slagelse Sygehus. After inclusion and baseline measurements, each individual will be randomized into either an intervention or control group arranged in blocks of 8 The intervention group (n≤19) will receive protein enriched snacks/dishes in the morning and late evening, before bedtime. Moreover, upon discharge the intervention group will receive individual dietary counseling focusing on choosing protein-rich foods and on protein rich meals. The control group (n≤19) will receive normal hospital food without enrichment and no dietary counseling at discharge. In both groups the following data will be obtained: recorded protein intake, anthropometric measurements (weight, height, body composition estimated with bioimpedance), functional ability (De Morton Mobility Index (DEMMI) and Barthels ADL-index), hand grip strength, sarkopenic status (SARC-F), quality of life (EQ-5D-3L), length of stay (LOS) and readmissions (within 30 days after discharge). During hospitalization food intake will be registered, as well as 24 hour recall interviews and food frequency questionnaires will be done at follow-up visits.

Assessments will be performed at baseline, on the day of discharge and 4 weeks after discharge (follow up).

The primary outcome is change in protein intake from Baseline to 4 weeks after discharge.

The hypothesis is that serving of individually selected protein enriched snack/dish in the morning and before bedtime during hospitalization results in higher protein intake during hospitalization and that this experience combined with dietary counseling at discharge, results in a higher protein intake at 28 days after discharge. Further, we hypothesize that the increased protein intake will affect functional level, hand grip strength, sarcopenic status and quality of life in geriatric patients and will lead to shorter LOS and fewer readmission frequency.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ingemannsvej 18
      • Slagelse, Ingemannsvej 18, Denmark, 4200
        • Slagelse Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: ≥65 år and admitted to the geriatric ward at Slagelse Hospital.
  • Expected length-of-stay, LOS: more than 3 days
  • Normal kidney function. (As long as the kidney values remain stable during the intervention it is deemed safe to take part, as the amount of protein given will not exceed the amount recommended by the Danish authorities.

Exclusion Criteria:

  • Dysphagia
  • Patients exclusively fed by tube/probe or parenteral nutrition.
  • Gastrointestinal problems, that makes normal food intake impossible.
  • People suffering from dementia, deliriousness or severe memory loss
  • Patients abusing alcohol
  • Patients in isolation
  • Terminal patients
  • Patients that do not speak Danish or English
  • Patients suffering from food allergies/intolerances that makes it impossible to accommodate to the protein enriched foods.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Protein supplement

During hospitalization the intervention group will receive a protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.

Diet registration and testing at baseline, discharge and follow-up.

During hospitalization the intervention group will receive a whey protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.

The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.

Both groups have diet registration and testing at baseline, discharge and follow-up.

No Intervention: Standard treatment

The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.

Diet registration and testing at baseline, discharge and follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein intake
Time Frame: Change from baseline up to 6 weeks
Dietary recordings with focus on protein intake are collected during hospitalization and at follow up. The total intake of protein per day is assessed.
Change from baseline up to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in grib strength
Time Frame: Baseline, up to 8 days, up to 6 weeks
Isometric hand grib strength. The patients sit in an upright position, resting their arm and holding a hand dynamometer in the non-dominant arm. Then a maximum pressure test is performed with the hand and the strength is recorded.
Baseline, up to 8 days, up to 6 weeks
De Morton Mobility Index (DEMMI)
Time Frame: Baseline, up to 8 days, up to 6 weeks
A mobility test used as standard procedure when admitted to the geriatric ward. The test contains 15 tasks of different difficulty, such as rising from a chair, static and dynamic balance and walk.
Baseline, up to 8 days, up to 6 weeks
Barthel ADL-index
Time Frame: Baseline, up to 8 days, up to 6 weeks
Testing the patient's ability to perform different activities of daily living, such as eating, movement, personal hygiene and toilet visits. The test consists of 10 steps, and each step results in a score from 5-15 when performed by the patient.
Baseline, up to 8 days, up to 6 weeks
SARC-F
Time Frame: Baseline, up to 8 days, up to 6 weeks
A screening tool, where the patient is asked about different physical parameters in relation to the risk of developing sarcopenia: parameters such as falls, assistance to walk, general strength, rise from a chair and walk on stairs.
Baseline, up to 8 days, up to 6 weeks
EQ-5D-3L
Time Frame: Baseline, up to 8 days, up to 6 weeks
A questionnaire focusing on self-perceived quality of life. The questions are divided into 5 categories: mobility, personal hygiene, pain, anxiety and ability to perform ADL-activities.
Baseline, up to 8 days, up to 6 weeks
Length of stay (LOS)
Time Frame: Up to 8 days (after baseline)
Based on information from electronic patient journal. LOS is defined from day of admission to day of discharge.
Up to 8 days (after baseline)
Readmission
Time Frame: Up to 6 weeks (after baseline)
Based on information from electronic patient journal and is defined as a readmission less than 30 days after discharge.
Up to 6 weeks (after baseline)
Anthropometric measures
Time Frame: Change from baseline up to 6 weeks
Weight is measured to make individual calculations of protein and energy needs.
Change from baseline up to 6 weeks
Bioimpedance
Time Frame: Up to 2 days and up to 6 weeks
Measurement of fat and muscle distribution in the body. Is measured on day 2-3 after inclusion because of possible irregularities in fluid balance at admission to the hospital and after surgery
Up to 2 days and up to 6 weeks
24h recall interview
Time Frame: Up to 6 weeks
Interviewers asks the participant about their dietary intake through the last 24 hours. A standard technique with four steps is used for this interview.
Up to 6 weeks
Food frequency questionnaire
Time Frame: Up to 6 weeks
A list containing the most protein rich food items are given to the participant and they are asked how frequent they have had the items during the last 4 weeks after discharge.
Up to 6 weeks
Nutrition related complications
Time Frame: Up to 8 days and up to 6 weeks.
Infections, falls and decreased wound healing
Up to 8 days and up to 6 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2017

Primary Completion (Actual)

June 30, 2017

Study Completion (Actual)

August 30, 2017

Study Registration Dates

First Submitted

February 10, 2017

First Submitted That Met QC Criteria

March 3, 2017

First Posted (Actual)

March 9, 2017

Study Record Updates

Last Update Posted (Actual)

May 3, 2018

Last Update Submitted That Met QC Criteria

May 2, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatric Diseases

Clinical Trials on Whey protein supplement

3
Subscribe